ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ ArticleЗырянов С.К., Белевский А.С., Дьяков И.Н.Астма и аллергия. 2019. С. 28-37
EFFICIENCY AND SAFETY OF OPIOID THERAPY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH CANCER OF THE REFRACTORY IRON: CLINICO-PATHOGENETIC FEATURES ArticleBobrova O.P., Schneider N.A., Petrova M.M., Dmitrenko D.V., Zyryanov S.K., Zobova S.N.Экспериментальная и клиническая гастроэнтерология. 2019. С. 45-51
SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE ArticleShmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 142 с.
AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondratieva E.I., Kondakova Y.A., Zyryanov S.K., Bondareva I.B., Voronkova A.Y., Sherman V.D., Melyanovskaya Y.L., Odinayeva N.D., Dronov I.A.Pediatriya - Zhurnal im G.N. Speranskogo. Том 98. 2019. С. 179-188
THE FIRST RUSSIAN CONSENSUS ON QUANTITATIVE ASSESSMENT OF TREATMENT OUTCOME ArticleArutyunov A.G., Bojcov S.A., Viktorova I.A., Vlasov V.V., Voevoda M.I., Vorob'yov P.A., Drapkina O.M., Zadionchenko V.S., Zarubina T.V., Zyryanov S.K., Karpov R.S., Kobalava Z.D., Kolbasnikov S.V., Lazebnik L.B., Livzan M.A., Malyavin A.G., Martynov A.I., Medvedeva I.V., Moiseev S.V., Napalkov D.A. ...Medical News of North Caucasus. Том 14. 2019. С. 283-301
CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH ArticleTolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 11. 2019. С. 48-60
BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS ArticleDiakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.Medical Technologies. Assessment and Choice. 2019. С. 71-80
GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE ArticleTkacheva O.N., Belenkov Y.N., Karpov Y.A., Zyryanov S.K.Kardiologiia. Том 59. 2019. С. 54-63
QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS ArticleIvanov D.A., Kubaeva M.B., Zyryanov S.K.Фармакоэкономика: теория и практика. Том 7. 2019. С. 38-39
PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION ArticleZyryanov S.K., Diyakov I.N., Avdeev S.N.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 268-278
THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER ArticleBobrova Olga, Schnider Natalya, Zyryanov Sergey, Dmitrenko Diana, Zobova Svetlana, Zukov RuslanКачественная клиническая практика. 2019. С. 53-59
CARDIOVASCULAR COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITORS ArticleKulieva A.A., Emelina E.I., Gendlin G.E., Nikitin I.G., Zyryanov S.K., Varentsov S.I., Zakharova I.I.Качественная клиническая практика. 2019. С. 55-65
SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC ArticleUshkalova E.A., Zyryanov S.K., Zalolochina K.E.Медицинский совет. 2019. С. 110-120
CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND ArticleBobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.Russian Open Medical Journal. Том 8. 2019.
PHARMACOLOGY IN SPECIAL POPULATIONS: EXTREME AGE ArticleRomanov B.K., Zyryanov S.K.Качественная клиническая практика. 2019. С. 70-74
DRUG ADJUSTMENT OF MODIFIED RISK FACTORS AS ONE OF THE LEADING STRATEGIES FOR MANAGING PATIENTS WITH CARDIOVASCULAR DISEASES ArticleZyryanov S.K., Baybulatova E.A.Медицинский совет. 2019. С. 22-38
PHARMACOKINETICS OF ANTI-BACTERIAL PREPARATIONS IN CYSTIC FIBROSIS IN CHILDREN ArticleKondakova Y.A., Voronkova A.Y., Zyryanov S.K., Bondareva I.B.Сибирское медицинское обозрение. 2019. С. 5-13
CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2019. С. 23-32
THERAPEUTIC DRUG MONITORING OF LEVETIRACETAM IN NEWBORNS ArticleBondareva I.B., Ivzhits M.A., Zyryanov S.K., Chenkurov M.S.Анналы клинической и экспериментальной неврологии. Том 13. 2019. С. 65-76
MODERN APPROACHES TO IMPROVING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN PERINATOLOGY: LOCAL EXPERIENCE ArticleKazanova A.M., Zyryanov S.K., Ivzhits M.A., Kruglov A.N., Kutsaya K.O., Chenkurov M.S.Качественная клиническая практика. 2019. С. 66-74
PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE ArticleAl-Rajavi A., Zyryanov S.K., Ushkalova E.A., Butranova O.I., Pereverzev A.P.Качественная клиническая практика. 2019. С. 57-65
CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA ArticleZyrianov S.K., Diakov I.N.Medical Technologies. Assessment and Choice. Том 36. 2019. С. 59-68
PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS ArticleZyryanov S.K., Dyakov I.N., Khachatryan N.N.Качественная клиническая практика. 2019. С. 55-69
PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA ArticleCheberda A.E., Belousov D.Yu., Zyryanov S.K.Качественная клиническая практика. 2018. С. 53-65
PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD ArticleZyryanov S.K., D'yakov I.N.Pulmonologiya. Том 28. 2018. С. 61-68